IS THERE A RISK OF METABOLIC SIDE EFFECTS WITH BISPHOSPHONATES?

被引：0
|
作者：
Zhelyazkova-Savova, M. [1 ]
Gancheva, S. [1 ]
机构：
[1] Varna Med Univ, Dept Pharmacol & Clin Pharmacol & Therapeut, Varna, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P549
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [31] Managing the Metabolic Side Effects of Atypical Antipsychotics
    Pearson, Geraldine
    JOURNAL OF CHILD AND ADOLESCENT PSYCHIATRIC NURSING, 2012, 25 (01) : 54 - 55
  • [32] No VTE risk with bisphosphonates
    Nassabeh N.
    Nature Reviews Rheumatology, 2010, 6 (3) : 118 - 118
  • [33] Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials
    Domotor, Zsuzsa Reka
    Vorhendi, Nora
    Hanak, Lilla
    Hegyi, Peter
    Kiss, Szabolcs
    Csiki, Endre
    Szako, Lajos
    Parniczky, Andrea
    Eross, Balint
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [34] ROLE OF SIDE EFFECTS, PHYSICIAN INVOLVEMENT AND PATIENT PERCEPTION IN DISCONTINUING OR SWITCHING OF ORAL BISPHOSPHONATES
    Rouach, V.
    Gez, S.
    Yu, J.
    Goldshtein, I.
    Goldstein, D.
    Ish-Shalom, S.
    Chodick, G.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S337 - S337
  • [35] Use of bisphosphonates and the cost of treating gastrointestinal side effects in a UK clinical practice setting
    Urdahl, HF
    Young, P
    McKendrick, J
    Freemantle, N
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S11 - S12
  • [36] Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation
    Berruti, A.
    Tucci, M.
    Generali, D.
    Mosca, A.
    Ardine, M.
    Vana, F.
    Dogliotti, L.
    ANNALS OF ONCOLOGY, 2006, 17 (12) : 1854 - 1855
  • [37] Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference
    Fadda, V.
    Maratea, D.
    Trippoli, S.
    Messori, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (02) : 189 - 192
  • [38] Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference
    V. Fadda
    D. Maratea
    S. Trippoli
    A. Messori
    Journal of Endocrinological Investigation, 2015, 38 : 189 - 192
  • [39] Bisphosphonates in the treatment of metabolic bone diseases
    Arantes, Henrique Pierotti
    da Silva, Andre Goncalves
    Lazaretti-Castro, Marise
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (02) : 206 - 212
  • [40] Bisphosphonates and metabolic bone disease in the ICU
    Hollander, Jason M.
    Mechanick, Jeffrey L.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2009, 12 (02): : 190 - 195
12345